CONTOUR Next EZ will be available this summer.

Bayer receives FDA clearance for brand-new blood sugar monitoring system Today announced that the U Bayer HealthCare.S.S., CONTOUR Next EZ will be available this summer.g. Acetaminophen, supplement C).Researchers have unsuccessfully tried to develop a drug to inhibit K-Ras for some 30 years. ‘RAS proteins including KRAS have not been 'druggable' for many decades despite a full lot of effort from academia and market,’ said senior author Dr. Kenneth Westover, Assistant Professor of Radiation Biochemistry and Oncology, and a member of UT Southwestern's Harold C. Simmons Cancer tumor Center. Related StoriesOvarian malignancy patients with a brief history of oral contraceptive use possess better outcomesScientists discover little molecule that can block development of BRCA-deficient tumor cellsCrucial change in one DNA base predisposes kids to aggressive type of tumor’We are discovering irreversible inhibitors as a remedy, which we believe may pave the way for the advancement of KRAS-targeted compounds with therapeutic potential as well as perhaps compounds that focus on other RAS family members proteins involved in cancer,’ Dr.